How is the Cellectar Biosciences Inc today?

The Cellectar Biosciences Inc today is trading in the down by -7.89% at 0.35.

How has Cellectar Biosciences Inc performed historically?

The Cellectar Biosciences Inc is currently trading down -7.89% on an intraday basis in the past week the index fell -2.78%. The index has been up 9.38% in the past quarter and fell -89.13% in the past year. You can view this in the overview section.

What is Cellectar Biosciences Inc Annual Net Profit?

Cellectar Biosciences Inc Annual Net Profit fell 4.23% in the last year to $44.58 M. Its sector's average net profit growth for the last fiscal year was -14.01%.

What is Cellectar Biosciences Inc Price to Earning Ratio?

Cellectar Biosciences Inc Price to Earning Ratio is -0.66, which is negative.

What is Cellectar Biosciences Inc Stock Price?

Cellectar Biosciences Inc Stock Price fell 89.13% and underperformed its sector by 633.97% in the past year.

What is Cellectar Biosciences Inc Quarterly Net profit?

Cellectar Biosciences Inc Quarterly Net profit rose 75.21% YoY to $6.6 M. Its sector's average net profit growth YoY for the quarter was -236.71%.

What is Cellectar Biosciences Inc Debt to Equity Ratio?

Cellectar Biosciences Inc Debt to Equity Ratio of 0.04 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Cellectar Biosciences Inc Mutual Fund Holding?

Cellectar Biosciences Inc Mutual Fund Holding increased by 0.15% in the last quarter to 8.53.

What is Cellectar Biosciences Inc Promoter Share Holding?

Cellectar Biosciences Inc Promoter Share Holding stayed the same in the most recent quarter at 2.76%.

What is Cellectar Biosciences Inc Institutional Holding?

Cellectar Biosciences Inc Institutional Holding decreased by 0.95% in the last quarter to 10.38.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
CELLECTAR BIOSCIENCES INC

Cellectar Biosciences Inc XNAS: CLRB

Cellectar Biosciences Inc Live Share Price Today, Share Analysis and Chart

Name: Cellectar Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Cellectar Biosciences Inc
Rating: 1.35791675
Author: Trendlyne DVM scores

about

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid d...

0.35 -0.03 (-7.89%)

89.16% Fall from 52W High

2.4M

XNAS Volume

XNAS 17 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

8.2 / 100

Technically Neutral

46.2 / 100

No estimates available

Cellectar Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cellectar Biosciences Inc Live Share Price Today, Share Analysis and Chart

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid d...

89.16% Fall from 52W High

SWOT Analysis

Cellectar Biosciences Inc Live Price Chart

Cellectar Biosciences Inc FAQ

How is Cellectar Biosciences Inc today?

Cellectar Biosciences Inc today is trading in the red, and is down by -7.89% at 0.35.

How has Cellectar Biosciences Inc performed historically?

Cellectar Biosciences Inc is currently trading down -7.89% on an intraday basis. In the past week the stock fell -2.78%. stock has been up 9.38% in the past quarter and fell -89.13% in the past year. You can view this in the overview section.